Screener
NeoGenomics NEO Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| LOSS FROM OPERATIONS | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income, net | (17) | 482 | (29) | 547 |
| Gain on extinguishment of debt (Note 6) | 11,181 | — | 11,181 | — |
| Income (loss) before taxes | 1,826 | (45,816) | (15,752) | (71,473) |
| Income tax benefit | 412 | 724 | 884 | 458 |
| NET INCOME (LOSS) | $2,238 | $(45,092) | $(14,868) | $(71,015) |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's other income (expense)?
- NeoGenomics (NEO) reported other income (expense) of -$17K in Q2 2026.
- How has NeoGenomics's other income (expense) changed year-over-year?
- NeoGenomics's other income (expense) decreased by 103.5% year-over-year, from $482K to -$17K.
- What is the long-term trend for NeoGenomics's other income (expense)?
- Over 4 years (2021 to 2025), NeoGenomics's other income (expense) has grown at a -51.9% compound annual growth rate (CAGR), from -$5.52M to $296K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about NeoGenomics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude